BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24320808)

  • 21. [Mycosis fungoides in childhood and adolescence with clonal T-cell receptor gamma gene rearrangement. Two cases].
    Krokowski M; Winzer M; Lange K; Thorns C; Gafumbegete E; Feller AC; Merz H
    Hautarzt; 2003 Jun; 54(6):536-40. PubMed ID: 12759739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypopigmented Mycosis Fungoides Mimicking Vitiligo.
    Kim JC; Kim YC
    Am J Dermatopathol; 2021 Mar; 43(3):213-216. PubMed ID: 33156019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypopigmented mycosis fungoides: case reports and literature review.
    Qari MS; Li N; Demierre MF
    J Cutan Med Surg; 2000 Jul; 4(3):142-8. PubMed ID: 11003719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypopigmented mycosis fungoides: a clinical mimicker of vitiligo.
    Tolkachjov SN; Comfere NI
    J Drugs Dermatol; 2015 Feb; 14(2):193-4. PubMed ID: 25689815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitiligo vs. hypopigmented mycosis fungoides (histopathological and immunohistochemical study, univariate analysis).
    El-Darouti MA; Marzouk SA; Azzam O; Fawzi MM; Abdel-Halim MR; Zayed AA; Leheta TM
    Eur J Dermatol; 2006; 16(1):17-22. PubMed ID: 16436337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.
    Li JY; Pulitzer MP; Myskowski PL; Dusza SW; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2013 Sep; 69(3):366-74. PubMed ID: 23685027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycosis Fungoides: Experience in a Pediatric Hospital.
    Cervini AB; Torres-Huamani AN; Sanchez-La-Rosa C; Galluzzo L; Solernou V; Digiorge J; Rubio P
    Actas Dermosifiliogr; 2017; 108(6):564-570. PubMed ID: 28279399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of hypopigmented mycosis fungoides in Egyptian patients presenting with hypopigmented lesions of the trunk.
    Abdel-Halim M; El-Nabarawy E; El Nemr R; Hassan AM
    Am J Dermatopathol; 2015 Nov; 37(11):834-40. PubMed ID: 26262921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypopigmented mycosis fungoides: frequent expression of a CD8+ T-cell phenotype.
    El-Shabrawi-Caelen L; Cerroni L; Medeiros LJ; McCalmont TH
    Am J Surg Pathol; 2002 Apr; 26(4):450-7. PubMed ID: 11914622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
    Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
    Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric follicular mucinosis: presentation, histopathology, molecular genetics, treatment, and outcomes over an 11-year period at the Mayo Clinic.
    Alikhan A; Griffin J; Nguyen N; Davis DM; Gibson LE
    Pediatr Dermatol; 2013; 30(2):192-8. PubMed ID: 23278316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folliculotropic mycosis fungoides: clinicopathological analysis of 17 patients.
    Marschalkó M; Erős N; Kontár O; Hidvégi B; Telek J; Hársing J; Jókai H; Bottlik G; Rajnai H; Szepesi Á; Matolcsy A; Kárpáti S; Csomor J
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):964-72. PubMed ID: 25406034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mycosis fungoides in children and adolescents: a report of six cases with predominantly hypopigmentation, along with a literature review].
    Rizzo FA; Vilar EG; Pantaleão L; Fonseca EC; Magrin PF; Henrique-Xavier M; Rochael MC
    Dermatol Online J; 2012 Mar; 18(3):5. PubMed ID: 22483516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypopigmented mycosis fungoides in Egyptian patients.
    Hassab-El-Naby HM; El-Khalawany MA
    J Cutan Pathol; 2013 Apr; 40(4):397-404. PubMed ID: 23379648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric mycosis fungoides in Singapore: a series of 46 children.
    Heng YK; Koh MJ; Giam YC; Tang MB; Chong WS; Tan SH
    Pediatr Dermatol; 2014; 31(4):477-82. PubMed ID: 24890628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+, CD56+ mycosis fungoides: case report and review of the literature.
    Horst BA; Kasper R; LeBoit PE
    Am J Dermatopathol; 2009 Feb; 31(1):74-6. PubMed ID: 19155730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
    Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT
    Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
    Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
    J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basement membrane thickness helps to differentiate hypopigmented mycosis fungoides from clinical and pathological mimickers.
    Abdelkader HA
    Int J Dermatol; 2023 Aug; 62(8):1013-1019. PubMed ID: 37212637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.